Article Publish Status: FREE
Abstract Title:

Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension.

Abstract Source:

JACC Basic Transl Sci. 2021 Jan ;6(1):12-21. Epub 2021 Jan 6. PMID: 33532663

Abstract Author(s):

Emily S Lau, Elizabeth Liu, Samantha M Paniagua, Amy A Sarma, Giovanna Zampierollo, Begoña López, Javier Díez, Thomas J Wang, Jennifer E Ho

Article Affiliation:

Emily S Lau


We investigated the effect of galectin-3 (Gal-3) inhibition with modified citrus pectin on markers of collagen metabolism in a proof-of-concept randomized placebo-controlled trial of participants with elevated Gal-3 levels and hypertension. Although higher Gal-3 levels were associated with female sex, diabetes, and reduced glomerular filtration rate in cross-sectional analyses, treatment with modified citrus pectin did not change collagen markers. The effect of Gal-3 inhibition among individuals with heart failure warrants further investigation.

Study Type : Human Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.